Table 2.
Variables | Test (n = 41) | Placebo (n = 37) | p-Value * | |
---|---|---|---|---|
Calories (kcal/day) | ||||
Baseline | 1687 (685) | 1728 (623) | 0.777 | |
6 weeks | 1577 (336) | 1676 (391) | 0.495 | |
12 weeks | 1597 (521) | 1732 (732) | 0.255 | |
Δ6 week-baseline | −94 (522) | −106 (537) | 0.948 | |
Δ12 week-baseline | −63 (853) | 17 (653) | 0.508 | |
Physical activity (MET-min/week) | ||||
Vigorous | Baseline | 0 (720) | 0 (720) | 0.923 |
6 weeks | 0 (800) | 0 (720) | 0.839 | |
12 weeks | 0 (1200) | 0 (720) | 0.577 | |
Δ6 week-baseline | 0 (240) | 0 (0) | 0.216 | |
Δ12 week-baseline | 0 (240) ** | 0 (320) | 0.043 | |
Moderate | Baseline | 0 (360) | 0 (240) | 0.978 |
6 weeks | 0 (480) | 0 (360) | 0.848 | |
12 weeks | 0 (360) | 0 (320) | 0.342 | |
Δ6 week-baseline | 0 (360) | 0 (120) | 0.881 | |
Δ12 week-baseline | 0 (360) | 0 (160) | 0.436 | |
Walking | Baseline | 495 (7590) | 693 (924) | 0.027 |
6 weeks | 594 (4158) | 693 (1320) | 0.157 | |
12 weeks | 792 (1056) | 924 (1386) | 0.344 | |
Δ6 week-baseline | 0 (561) | 198 (957) | 0.753 | |
Δ12 week-baseline | 0 (660) ** | 0 (462) | 0.146 | |
Total | Baseline | 990 (1941) | 1746 (3465) | 0.080 |
6 weeks | 1386 (1839) | 1386 (2493) | 0.473 | |
12 weeks | 1386 (2319) | 1710 (2136) | 0.625 | |
Δ6 week-baseline | 141 (1287) | 247 (2331) | 0.705 | |
Δ12 week-baseline | 240 (1761) ** | –9 (1062) | 0.043 |
Data are presented as the median (interquartile range). * p-values were calculated using Wilcoxon rank sum test. ** were represented as having p-values <0.05 in the Wilcoxon signed rank test for comparison within-group differences.